Neonatal seizures as onset of Inborn Errors of Metabolism (IEMs): from diagnosis to treatment. A systematic review
Authors:
Open Access
- 17 August 2021
- journal article
- review article
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 36 (8) , 2195-2203
Abstract
Neonatal seizures (NS) occur in the first 28 days of life; they represent an important emergency that requires a rapid diagnostic work-up to start a prompt therapy. The most common causes of NS include: intraventricular haemorrhage, hypoxic-ischemic encephalopathy, hypoglycemia, electrolyte imbalance, neonatal stroke or central nervous system infection. Nevertheless, an Inborn Error of Metabolism (IEM) should be suspected in case of NS especially if these are resistant to common antiseizure drugs (ASDs) and with metabolic decompensation. Nowadays, Expanded Newborn Screening (ENS) has changed the natural history of some IEMs allowing a rapid diagnosis and a prompt onset of specific therapy; nevertheless, not all IEMs are detected by such screening (e.g. Molybdenum-Cofactor Deficiency, Hypophosphatasia, GLUT1-Deficiency Syndrome) and for this reason neonatologists have to screen for these diseases in the diagnostic work-up of NS. For IEMs, there are not specific semiology of seizures and EEG patterns. Herein, we report a systematic review on those IEMs that lead to NS and epilepsy in the neonatal period, studying only those IEMs not included in the ENS with tandem mass, suggesting clinical, biochemical features, and diagnostic work-up. Remarkably, we have observed a worse neurological outcome in infants undergoing only a treatment with common AED for their seizures, in comparison to those primarily treated with specific anti-convulsant treatment for the underlying metabolic disease (e.g.Ketogenic Diet, B6 vitamin). For this reason, we underline the importance of an early diagnosis in order to promptly intervene with a targeted treatment without waiting for drug resistance to arise.Keywords
Funding Information
- Università degli Studi di Catania
This publication has 28 references indexed in Scilit:
- Case Report: Intravenous and Oral Pyridoxine Trial for Diagnosis of Pyridoxine-Dependent EpilepsyPediatrics, 2015
- Neonatal seizures: Aetiology by means of a standardized work-upEuropean Journal of Paediatric Neurology, 2014
- Metabolic epilepsy: An updateBrain and Development, 2013
- Hypophosphatasia Presenting with Pyridoxine-Responsive Seizures, Hypercalcemia, and Pseudotumor Cerebri: Case ReportJournal of Clinical Research in Pediatric Endocrinology, 2012
- Isolated Neonatal Seizures: When to Suspect Inborn Errors of MetabolismPediatric Neurology, 2011
- Pyridoxine‐dependent epilepsy: An under‐recognised cause of intractable seizuresJournal of Paediatrics and Child Health, 2010
- Neonatal Seizures: When to Consider and How to Investigate for an Inborn Error of MetabolismProceedings of Singapore Healthcare, 2010
- Pyridoxine-responsive seizures as the first symptom of infantile hypophosphatasia caused by two novel missense mutations (c.677T>C, p.M226T; c.1112C>T, p.T371I) of the tissue-nonspecific alkaline phosphatase geneBone, 2007
- Molybdenum cofactor deficiencyThe Journal of Pediatrics, 1993
- Molybdenum-Cofactor Deficiency: An Easily Missed Cause of Neonatal ConvulsionsNeuropediatrics, 1993